P. Benn

H. Cuckle, E. Pergament, P. Benn, 2014, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Angelman syndrome associated with an inversion of chromosome 15q11.2q24.3.

S. Rosengren, J. Knoll, M. Lalande, 1997, American journal of human genetics.

Practical strategies in contingent sequential screening for Down syndrome

H. Cuckle, D. Wright, P. Benn, 2005, Prenatal diagnosis.

Validation of a Single-Nucleotide Polymorphism-Based Non-Invasive Prenatal Test in Twin Gestations: Determination of Zygosity, Individual Fetal Sex, and Fetal Aneuploidy

M. Rabinowitz, Z. Demko, E. Norwitz, 2019, Journal of clinical medicine.

Specific chromosome aberrations in senescent fibroblast cell lines derived from human embryos.

P. Benn, 1976, American journal of human genetics.

The role of the BCR/ABL oncogene in human leukemia

P. Benn, 1995 .

Correlation of Second‐Trimester Sonographic and Biochemical Markers

D. Nyberg, D. Luthy, F. Luthardt, 2004, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Quality Assurance of Non-Invasive Prenatal Screening (NIPS) for Fetal Aneuploidy Using Positive Predictive Values as Outcome Measures

Z. Demko, S. Zneimer, P. Benn, 2019, Journal of clinical medicine.

Clinical experience with a single‐nucleotide polymorphism‐based non‐invasive prenatal test for five clinically significant microdeletions

A. Simon, Z. Demko, M. Stosic, 2018, Clinical genetics.

a few benefits and many concerns

P. Benn, Audrey R. Chapman, 2014 .

Comparison of high resolution chromosome banding and fluorescence in situ hybridization (FISH) for the laboratory evaluation of Prader-Willi syndrome and Angelman syndrome.

S. Rosengren, R. Greenstein, S. Cassidy, 1994, American journal of medical genetics.

Posttest risk calculation following positive noninvasive prenatal screening using cell-free DNA in maternal plasma.

P. Benn, 2016, American journal of obstetrics and gynecology.

Nuchal translucency and cardiac abnormalities in euploid singleton pregnancies

A. Borgida, A. Shamshirsaz, A. Shamshirsaz, 2014, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

A Critical Evaluation of Validation and Clinical Experience Studies in Non-Invasive Prenatal Testing for Trisomies 21, 18, and 13 and Monosomy X

Z. Demko, P. Benn, Brittany Prigmore, 2022, Journal of clinical medicine.

ACOG Committee Opinion No. 279: Prevention of Early‐Onset Group B Streptococcal Disease in Newborns

P. Benn, 2002, Obstetrics and gynecology.

Assignment of a gene for uridine diphosphate galactose-4-epimerase to human chromosome 1 by somatic cell hybridization, with evidence for a regional assignment to 1pter yields 1p21.

T. Shows, C. Croce, P. Benn, 1979, Cytogenetics and cell genetics.

Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis

L. Dugoff, K. Spencer, Tianhua Huang, 2015, Prenatal diagnosis.

Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis

L. Dugoff, K. Spencer, Tianhua Huang, 2013, Prenatal diagnosis.

Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA

C. Izzi, F. Prefumo, T. Ghi, 2019, Genetics in Medicine.

The origins of aneuploidy research consortium

H. Cuckle, E. Pergament, P. Benn, 2021, Prenatal diagnosis.

Treatment of Synchronous Mantle Cell Lymphoma and Small Lymphocytic Lymphoma with Bendamustine and Rituximab

T. Kourelis, B. Kahl, P. Benn, 2011, Acta Haematologica.

Comparison of phenotyping and genotyping of lymphoid neoplasms

V. Vinciguerra, A. Eisenberg, P. Benn, 1989, Journal of clinical laboratory analysis.

Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia.

P. Gascón, R. Silver, E. Camposano, 1989, American journal of human genetics.

Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions.

P. Benn, 2002, Clinica chimica acta; international journal of clinical chemistry.

Does the site of the breakpoint on chromosome 22 influence the duration of the chronic phase in chronic myeloid leukemia?

K. Mills, G. Birnie, P. Benn, 1989, Leukemia.

Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia

Jen-Chin Wang, P. Benn, H. Lang, 1992, British journal of haematology.

Subpopulations of cytogenetically abnormal cells in fibroblast cultures derived from workers exposed to mineral oil.

D. Harnden, P. Benn, E. Fairburn, 1978, Journal of the National Cancer Institute.

Sequential combined test, second trimester maternal serum markers, and circulating fetal cells to select women for invasive prenatal diagnosis

G. Calabrese, M. Alfonsi, D. Fantasia, 2017, PloS one.

Maternal cfDNA screening for Down syndrome – a cost sensitivity analysis

H. Cuckle, E. Pergament, P. Benn, 2013, Prenatal diagnosis.

Down syndrome births in the United States from 1989 to 2001.

J. Egan, A. Borgida, C. Zelop, 2004, American journal of obstetrics and gynecology.

Incorporation of Inhibin-A in Second-Trimester Screening for Down syndrome: In Reply * * None of the

J. Egan, P. Benn, M. Fang, 2003 .

Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.

J. Rodis, P. Benn, A. Craffey, 2000, The Journal of maternal-fetal medicine.

Predictive value of the triple screening test for the phenotype of Down syndrome.

S. Rosengren, S. Tanski, P. Benn, 1999, American journal of medical genetics.

Cost-effectiveness of estimating gestational age by ultrasonography in Down syndrome screening.

P. Benn, T. Beazoglou, J. Rodis, 1999, Obstetrics and gynecology.

Economic evaluation of prenatal screening for Down syndrome in the U.S.A.

A. Vintzileos, J. Kyriopoulos, D. Heffley, 1998, Prenatal diagnosis.

Theoretical performance of non‐invasive prenatal testing for chromosome imbalances using counting of cell‐free DNA fragments in maternal plasma

H. Cuckle, P. Benn, 2014, Prenatal diagnosis.

Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011

L. Dugoff, K. Spencer, H. Cuckle, 2012, Prenatal diagnosis.

Non‐invasive prenatal screening for fetal triploidy using single nucleotide polymorphism‐based testing: Differential diagnosis and clinical management in cases showing an extra haplotype

Z. Demko, P. Benn, W. DiNonno, 2022, Prenatal diagnosis.

Expanding non‐invasive prenatal testing beyond chromosomes 21, 18, 13, X and Y

P. Benn, 2016, Clinical genetics.

Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach

C. Eng, M. Rabinowitz, Z. Demko, 2020, Genetics in Medicine.

Current controversies in prenatal diagnosis 4: pre‐conception expanded carrier screening should replace all current prenatal screening for specific single gene disorders

S. Langlois, L. Wilkins-Haug, P. Benn, 2015, Prenatal diagnosis.

Aneuploidy screening using circulating fetal cells in maternal blood by dual‐probe FISH protocol: a prospective feasibility study on a series of 172 pregnant women

C. Celentano, G. Calabrese, M. Alfonsi, 2016, Molecular genetics & genomic medicine.

Prenatal counseling and the detection of copy-number variants

P. Benn, 2013, Genetics in Medicine.

Altered epidermal growth factor signal transduction in activated Ha-ras-transformed human keratinocytes.

J. Rhim, J. Mendelsohn, M. Clawson, 1993, Biochemical and biophysical research communications.

Aging chromosome telomeres: parallel studies with terminal repeat and telomere associated DNA probes

P. Benn, 1997, Mechanisms of Ageing and Development.

Clinical experience with single‐nucleotide polymorphism‐based non‐invasive prenatal screening for 22q11.2 deletion syndrome

A. Bassett, Z. Demko, J. Babiarz, 2016, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

A rare restriction enzyme site polymorphism in the breakpoint cluster region (bcr) of chromosome 22.

P. Gascón, A. Grossman, P. Benn, 1988, Leukemia.

Assessment of an automated approach for variant interpretation in screening for monogenic disorders: A single‐center study

Hamsa D. Tadepally, Z. Demko, Robin Munch, 2022, Molecular genetics & genomic medicine.

Practical and ethical considerations of noninvasive prenatal diagnosis.

P. Benn, Audrey R. Chapman, 2009, JAMA.

Review of the cytogenetic changes in acute megakaryoblastic leukemia: one disease or several?

P. Benn, G. Lu, A. J. Altman, 1993, Cancer genetics and cytogenetics.

Densitometric analysis of Southern blot autoradiographs and its application to monitoring patients with chronic myeloid leukemia.

R. Silver, R. Verma, A. Grossman, 1991, Leukemia.

Comment on “The clinical utility of genome‐wide non invasive prenatal screening”

F. Grati, P. Benn, 2017, Prenatal diagnosis.

Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.

T. Lerer, J. Wax, P. Benn, 2000, The Journal of maternal-fetal medicine.

Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: Recurrence risk and association with adverse perinatal outcome

T. Lerer, J. Wax, P. Benn, 2000 .

Prenatal Diagnosis of Chromosomal Abnormalities through Amniocentesis

Peter Benn, P. Benn, 2010 .

Maternal Serum Screening for Chromosomal Abnormalities and Neural Tube Defects

H. Cuckle, E. Pergament, P. Benn, 2015, Genetic Disorders and the Fetus.

Non‐invasive prenatal testing for aneuploidy: current status and future prospects

H. Cuckle, E. Pergament, P. Benn, 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Advances in prenatal screening for Down syndrome: I. general principles and second trimester testing.

Peter A Benn, P. Benn, 2002, Clinica chimica acta; international journal of clinical chemistry.

Multi‐Marker Maternal Serum Screening for Chromosomal Abnormalities

H. Cuckle, P. Benn, 2010 .

Prenatal Diagnosis of Chromosomal Abnormalities through Chorionic Villus Sampling and Amniocentesis

P. Benn, 2015, Genetic Disorders and the Fetus.

Prenatally diagnosed sacrococcygeal teratoma: a unique expression of trisomy 1q.

J. Wax, P. Benn, C. Ingardia, 2000, Cancer genetics and cytogenetics.

Proposed guidelines for diagnosis of chromosome mosaicism in amniocytes based on data derived from chromosome mosaicism and pseudomosaicism studies

K. Hirschhorn, A. Shanske, D. Warburton, 1992, Prenatal diagnosis.

Extreme second-trimester serum analyte values in Down syndrome pregnancies with hydrops fetalis

J. Egan, P. Benn, C. Ingardia, 2002, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups.

J. Clive, P A Benn, J M Clive, 1997, Clinical chemistry.

Cytogenetically marked clones in human fibroblasts cultured from normal subjects

A. Taylor, D. Harnden, T. Webb, 1976, Somatic cell genetics.

The centralized prenatal genetics screening program of New York City III: The first 7,000 cases.

P. Benn, L. Hsu, A. Carlson, 1985, American journal of medical genetics.

A fetus with a chromosome 13 ring and placenta with chromosome 13 rod/ring mosaicism

D. Warburton, J. Byrne, R. Rudelli, 1983, Prenatal diagnosis.

Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome

J. Rodis, P. Benn, A. Craffey, 2000 .

Preliminary evidence for associations between second‐trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies

P. Benn, 1998, Prenatal diagnosis.

Letter to the Editor. Down syndrome and open neural tube defect screen‐positive pregnancies: premature delivery and premature placental karyotyping

P. Benn, 1997, Prenatal diagnosis.

45,X/46,XX mosaicism in patients with idiopathic premature ovarian failure.

A. Luciano, P. Benn, D. Metzger, 1998, Fertility and sterility.

bcr breakpoint and prognosis of chronic phase chronic myeloid leukemia.

K. Mills, G. Birnie, P. Benn, 1990, Blood.

The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia.

R. Silver, M. Coleman, Z. Arlin, 1988, Leukemia.

Pediatric healthcare costs for patients with 22q11.2 deletion syndrome

Evanette K. Burrows, E. Zackai, K. Sullivan, 2017, Molecular genetics & genomic medicine.

Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes.

A. Siddiqui, P. Lacroute, M. Rabinowitz, 2015, American journal of obstetrics and gynecology.

Second trimester maternal serum analytes in triploid pregnancies: correlation with phenotype and sex chromosome complement

J. Egan, J. Rodis, P. Benn, 2001, Prenatal diagnosis.

Uniparental disomy: Origin, frequency, and clinical significance

P. Benn, 2020, Prenatal diagnosis.

Review of epidemiological factors (other than maternal age) that determine the prevalence of common autosomal trisomies

H. Cuckle, P. Benn, 2020, Prenatal diagnosis.

Rare autosomal trisomies detected by non-invasive prenatal testing

P. Benn, 2022, European Journal of Human Genetics.

Response to Sistermans et al.

F. Grati, P. Benn, Jose Ferreira, 2019, Genetics in Medicine.

Response to Toutain et al.

F. Grati, J. Ferreira, P. Benn, 2019, Genetics in Medicine.

Rare autosomal trisomies (RATs): a comparison of the detection through cell-free DNA and chorionic villus sampling.

G. Simoni, B. Grimi, F. Maggi, 2019, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing.

Matthew Rabinowitz, Allison Ryan, Milena Banjevic, 2014, American journal of obstetrics and gynecology.

Noninvasive prenatal testing for fetal aneuploidy: clinical assessment and a plea for restraint.

M. Norton, N. Rose, P. Benn, 2013, Obstetrics and gynecology.

RARE TRISOMY MOSAICISM DIAGNOSED IN AMNIOCYTES, INVOLVING AN AUTOSOME OTHER THAN CHROMOSOMES 13, 18, 20, AND 21: KARYOTYPE/PHENOTYPE CORRELATIONS

C L Bradshaw, L. Shaffer, C. Disteche, 1997, Prenatal diagnosis.

Clonal immunoglobulin gene rearrangements in chronic lymphocytic leukemia: A correlative study

R. Silver, P. Benn, M. Baird, 1988, American journal of hematology.

Performance of conventional cytogenetic analysis on chorionic villi when only one cell layer, cytotrophoblast or mesenchyme alone, is analyzed

G. Simoni, B. Grimi, F. Grati, 2021, Prenatal diagnosis.

Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011

L. Dugoff, K. Spencer, H. Cuckle, 2011, Prenatal diagnosis.

S100β protein and amniotic fluid

P. Benn, 2003 .

Prenatal genetic diagnosis of Down’s syndrome

M. Abbott, P. Benn, 2002, Expert review of molecular diagnostics.

Utility of molecular genetic analysis of bcr rearrangement in the diagnosis of chronic myeloid leukemia.

R. Silver, M. Coleman, P. Benn, 1987, Cancer genetics and cytogenetics.

Variable clinical expression of mosaic trisomy 16 in the newborn infant.

R. Greenstein, M. Velinov, P. Benn, 1993, American journal of medical genetics.

Trisomy 16 fetus surviving into the second trimester

J. Rodis, P. Benn, W. Cusick, 1995, Prenatal diagnosis.

Aneuploidy in first trimester chorionic villi and spontaneous abortions: Windows into the origin and fate of aneuploidy through embryonic and fetal development

F. Grati, P. Benn, 2020, Prenatal diagnosis.

Factors Associated With Informative Redraw After an Initial No Result in Noninvasive Prenatal Testing.

Z. Demko, E. Valenti, P. Benn, 2018, Obstetrics and gynecology.

Maternal serum screening for fetal trisomy 18: a comparison of fixed cutoff and patient-specific risk protocols.

J. Rodis, P. Benn, T. Beazoglou, 1999, Obstetrics and gynecology.

A high incidence of maternal cell contamination of amniotic fluid cell cultures.

P. Benn, L. Hsu, A. Schonhaut, 1983, American journal of medical genetics.

Non‐invasive prenatal testing in the management of twin pregnancies

A. Rebarber, P. Benn, 2021, Prenatal diagnosis.

Non‐invasive prenatal diagnosis for Down syndrome: the paradigm will shift, but slowly

H. Cuckle, E. Pergament, P. Benn, 2012, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Reversion from deficiency of galactose-1-phosphate uridylyltransferase (GALT) in an SV40-transformed human fibroblast line

R. Kelley, P. Benn, F. Boches, 1981, Somatic cell genetics.

Obstetricians and gynecologists' practice and opinions of expanded carrier testing and noninvasive prenatal testing

Mark S. DeFrancesco, J. Egan, L. Wilkins-Haug, 2014, Prenatal diagnosis.

Genome‐wide non‐invasive prenatal screening for all cytogenetically visible imbalances

F. Grati, P. Benn, 2018, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Current controversies in prenatal diagnosis 1: should NIPT routinely include microdeletions/microduplications?

N. Rose, A. Milunsky, P. Benn, 2016, Prenatal diagnosis.

Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.

H. Cuckle, E. Pergament, P. Benn, 2012, Obstetrics and gynecology.

Trends in the use of second trimester maternal serum screening from 1991 to 2003

J. Egan, P. Benn, M. Fang, 2005, Genetics in Medicine.

Contingent screening for Down syndrome is an efficient alternative to non‐disclosure sequential screening

K. Ritchie, H. Cuckle, I. Bradbury, 2004, Prenatal diagnosis.

Changes in the Utilization of Prenatal Diagnosis

R. Smith-Bindman, J. Egan, P. Benn, 2004, Obstetrics and gynecology.

Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach

C. Eng, M. Rabinowitz, Z. Demko, 2020, Genetics in Medicine.

On the genesis and prognosis of variant translocations in chronic myeloid leukemia.

Zihai Li, P. Benn, M. Fang, 2007, Cancer genetics and cytogenetics.

Cell-free DNA screening for fetal aneuploidy as a clinical service.

H. Cuckle, E. Pergament, Peter Benn, 2015, Clinical biochemistry.

Incidence and significance of supernumerary marker chromosomes in prenatal diagnosis.

P. Benn, L. Hsu, 1984, American journal of human genetics.

X-chromosome abnormalities in women with premature ovarian failure.

P. Benn, A. Devi, 1999, The Journal of reproductive medicine.

Combined Sonographic and Biochemical Markers for Down Syndrome Screening

J. Egan, J. Wax, A. Cartin, 2003, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Improved antenatal screening for Down's syndrome

P. Benn, 2003, The Lancet.

Incorporation of Inhibin‐A in Second‐Trimester Screening for Down Syndrome

J. Egan, P. Benn, M. Fang, 2003, Obstetrics and gynecology.

Antenatal Down syndrome screening in the United States in 2001: a survey of maternal-fetal medicine specialists.

J. Egan, A. Borgida, P. Benn, 2002, American journal of obstetrics and gynecology.

Estimates for the sensitivity and false‐positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross‐identification and double‐positive results

J. Egan, P. Benn, T. Beazoglou, 2001, Prenatal diagnosis.

Efficacy of Screening for Fetal Down Syndrome in the United States From 1974 to 1997

J. Egan, A. Borgida, J. Rodis, 2000, Obstetrics and gynecology.

Utilization of Amniocentesis by Women Screening Positive for Down Syndrome on the Second-Trimester Triple Test

D. Heffley, Jieling Chen, P. Benn, 2000, Public Health Genomics.

Survival of Down syndrome in utero

J. Egan, P. Benn, 2000, Prenatal diagnosis.

Positive predictive values and false-positive results in noninvasive prenatal screening.

P. Dar, S. Gross, P. Benn, 2015, American journal of obstetrics and gynecology.

Does the breakpoint within the major breakpoint cluster region (M-bcr) influence the duration of the chronic phase in chronic myeloid leukemia? An analytical comparison of current literature.

K. Mills, G. Birnie, P. Benn, 1991, Blood.

Impact of diabetes on aneuploidy screening.

W. Campbell, P. Benn, P. Gurram, 2013, Clinics in laboratory medicine.

Human lymphocyte culture and chromosome analysis.

P. Benn, J. Delach, 2008, Cold Spring Harbor Protocols.

Molecular characterization of variant translocations in chronic myelogenous leukemia.

J. Groffen, M. Macera, R. Verma, 1989, Oncogene.

Chromosomal polymorphisms of 1, 9, 16, and Y in 4 major ethnic groups: a large prenatal study.

T. Perlis, P. Benn, L. Hsu, 1987, American journal of medical genetics.

Non-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future Prospects

P. Benn, 2014, Journal of clinical medicine.

Noninvasive Prenatal Testing for Early Sex Identification: A Few Benefits and Many Concerns

P. Benn, Audrey R. Chapman, 2014, Perspectives in biology and medicine.

Steroid hormone receptor immunohistochemistry and amplification of c‐myc protooncogene relationship to disease‐free survival in breast cancer

A. C. Carter, J. Feldman, L. Pertschuk, 1993, Cancer.

Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities.

E. Norwitz, E. Pergament, P. Benn, 2016, American journal of obstetrics and gynecology.

Early growth response gene 1 (EGR1) is deleted in estrogen receptor‐negative human breast carcinoma

V. Moyo, J. Burleson, P. Benn, 2005, Cancer.

Expected performance of second trimester maternal serum testing followed by a ‘genetic sonogram’ in screening of fetal Down syndrome

J. Egan, P. Benn, 2008, Prenatal diagnosis.

Preliminary estimate for the second-trimester maternal serum screening detection rate of the 45,X karyotype using α-fetoprotein, unconjugated estriol and human chorionic gonadotropin

P. Benn, J. Ying, 2004, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Efficacy of the Genetic Sonogram in a Stepwise Sequential Protocol for Down Syndrome Screening

J. Egan, A. Borgida, A. Shamshirsaz, 2013, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Comparison of combined, stepwise sequential, contingent, and integrated screening in 7292 high‐risk pregnant women

G. Calabrese, P. Benn, I. Iezzi, 2011, Prenatal diagnosis.

The role of second-trimester serum screening in the post-first-trimester screening era.

J. Egan, A. Shamshirsaz, Peter Benn, 2010, Clinics in laboratory medicine.

Use of the Genetic Sonogram in the United States in 2001 and 2007

J. Egan, P. Benn, Y. Fang, 2008, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

GENETIC SONOGRAM: COMPONENTS AND ROLE IN THE ERA OF PRENATAL SCREENING

A. Shamshirsaz, W. Campbell, P. Benn, 2014 .

Combined Second‐Trimester Biochemical and Ultrasound Screening for Down Syndrome

J. Egan, A. Borgida, P. Benn, 2002, Obstetrics and gynecology.

Variation of Fetal Nasal Bone Length in Second‐Trimester Fetuses According to Race and Ethnicity

J. Egan, A. Borgida, C. Zelop, 2005, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Elevated Second‐Trimester Maternal Serum hCG Alone or in Combination With Elevated Alpha‐Fetoprotein

J. Clive, J. Rodis, P. Benn, 1996, Obstetrics and gynecology.

leukemia (letter; comment) bcr breakpoint and prognosis of chronic phase chronic myeloid

K. Mills, Birnie Gd, P. Benn, 2011 .

A new translocation involving chromosomes 8 and 9 in a Philadelphia-negative chronic myelogenous leukemia.

M. Macera, R. Silver, R. Verma, 1988, Cancer genetics and cytogenetics.

Positive predictive values and outcomes for uninformative cell‐free DNA tests: An Italian multicentric Cytogenetic and cytogenomic Audit of diagnOstic testing (ICARO study)

P. Gasparini, L. Bernardini, A. Novelli, 2022, Prenatal diagnosis.

Sequential Down Syndrome Screening: The Importance of First and Second Trimester Test Correlations when Calculating Risk

A. Donnenfeld, P. Benn, 2005, Journal of Genetic Counseling.

Which contingent sequential screening protocol?: A response

K. Ritchie, H. Cuckle, I. Bradbury, 2005 .

Which contingent sequential screening protocol?

K. Ritchie, H. Cuckle, I. Bradbury, 2005, Prenatal Diagnosis.

TRISOMY 16 MOSAICISM IN AMNIOTIC FLUID CELL CULTURES

P. Benn, UMADEVI TANTRAVAHI, C. Matsumoto, 1996, Prenatal diagnosis.

Acute Lymphoblastic Leukemia, FAB-L3, with t(8;14) and Precursor B Cell Immunophenotype: Case Report and Literature Review

W. Rezuke, P. Benn, W. Pogue, 1995 .

Reproducibility of risk figures in 2nd-trimester maternal serum screening for down syndrome: comparison of 2 laboratories.

J. Egan, D. Wright, P. Benn, 2006, Clinical chemistry.

CT ratios: parameter estimates are inconsistent with SURUSS publications?

K. Spencer, H. Cuckle, I. Bradbury, 2006, Prenatal diagnosis.

Population kinetics of chromosomally abnormal human fibroblast subpopulations.

P. Benn, 1977, Cytogenetics and cell genetics.

Screening for 22q11.2 deletion syndrome by two non-invasive prenatal testing methodologies: A case with discordant results.

P. Benn, L. Lo, S. S. Shaw, 2019, Taiwanese Journal of Obstetrics & Gynecology.

Maternal plasma cell-free DNA screening

H. Cuckle, P. Benn, 2019, New Technologies and Perinatal Medicine.

Attenuated familial adenomatous polyposis in a man with an interstitial deletion of chromosome arm 5q.

A. Brothman, R. Pilarski, P. Benn, 1999, American journal of medical genetics.

Assignment of the human gene for enolase 1 to region pter in equilibrium p36 of chromosome 1.

C. Croce, P. Benn, C. J. Chern, 1977, Cytogenetics and Cell Genetics.

Multiple restriction enzyme digests are required to rule out polymorphism in the molecular diagnosis of chronic myeloid leukemia.

P. Tiso, A. Grossman, P. Benn, 1990, Leukemia.

Absent or Shortened Nasal Bone Length and the Detection of Down Syndrome in Second-Trimester Fetuses

J. Egan, C. Zelop, P. Benn, 2007, Obstetrics and gynecology.

Specific break points in chromosomally abnormal human fibroblast subpopulations.

P. Benn, 1977, Cytogenetics and cell genetics.

TRISOMY-20 SYNDROME IN MAN

D. Harnden, P. Benn, 1976, The Lancet.

Maternal cell contamination of amniotic fluid cell cultures: results of a U.S. nationwide survey.

P. Benn, L. Hsu, 1983, American journal of medical genetics.

Common trisomy mosaicism diagnosed in amniocytes involving chromosomes 13, 18, 20 and 21: karyotype–phenotype correlations

L. Shaffer, S. Patil, C. Jackson-Cook, 2000, Prenatal diagnosis.

Correspondence on "Maternal carrier screening with single-gene NIPS provides accurate fetal risk assessments for recessive conditions" by Hoskovec et al.

P. Benn, 2023, Genetics in medicine : official journal of the American College of Medical Genetics.

Reproductive Carrier Screening Results With Maternal Health Implications During Pregnancy

Yang Wang, Emily Becraft, N. Sanapareddy, 2023, Obstetrics and gynecology.

Overview of Noninvasive Prenatal Testing (NIPT) for the Detection of Fetal Chromosome Abnormalities; Differences in Laboratory Methods and Scope of Testing.

H. Cuckle, P. Benn, 2023, Clinical obstetrics and gynecology.

Fetal fraction‐based risk algorithm for non‐invasive prenatal testing: screening for trisomies 13 and 18 and triploidy in women with low cell‐free fetal DNA

C. Grabarits, S. Kareht, D. Saltzman, 2018, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Highly complex genetic rearrangement involving at least seven breakpoints in a case of chronic myeloid leukemia.

A. Grossman, P. Benn, K. Dittmar, 1990, Cancer Genetics and Cytogenetics.

Revised guidelines for the diagnosis of mosaicism in amniocytes

P. Benn, LillianY. F. Hsu, 1999, Prenatal diagnosis.

578: An update on trends in down syndrome livebirths in the U. S. from 1989 to 2005

J. Egan, W. Campbell, P. Benn, 2008 .

Cell-free DNA screening for fetal aneuploidy as a clinical service.

H. Cuckle, E. Pergament, P. Benn, 2015, Clinical biochemistry.

A rapid (but wrong) prenatal diagnosis.

J. Rodis, R. Greenstein, L. Lettieri, 1992, The New England journal of medicine.

Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple-marker testing as screen positive for Down syndrome.

R. Greenstein, P. Benn, P. Benn, 1995, American journal of obstetrics and gynecology.

Maternal cfDNA screening for Down syndrome – a cost sensitivity analysis

H. Cuckle, E. Pergament, P. Benn, 2013, Prenatal diagnosis.

Reply: To PMID 25111587.

P. Dar, S. Gross, P. Benn, 2015, American journal of obstetrics and gynecology.

Assignment of the genes for human beta-glucuronidase and mitochondrial malate dehydrogenase to the region pter leads to q22 of chromosome 7.

G. Bruns, I. Craig, C. Croce, 1977, Cytogenetics and cell genetics.